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Kinetics of DNA and RNA Hybridization
in Serum and Serum-SDS
Elton Graugnard, Amber Cox, Jeunghoon Lee, Cheryl Jorcyk, Bernard Yurke, and William L. Hughes
Abstract—Cancer is recognized as a serious health challenge
both in the United States and throughout the world. While early
detection and diagnosis of cancer leads to decreased mortality
rates, current screening methods require significant time and costly
equipment. Recently, increased levels of certain micro-ribonucleic
acids (miRNAs) in the blood have been linked to the presence of
cancer. While blood-based biomarkers have been used for years in
cancer detection, studies analyzing trace amounts of miRNAs in
blood and serum samples are just the beginning. Recent develop-
ments in deoxyribonucleic acid (DNA) nanotechnology and DNA
computing have shown that it is possible to construct nucleic-acid-
based chemical networks that accept miRNAs as inputs, perform
Boolean logic functions on those inputs, and generate as an out-
put a large number of DNA strands that can be readily detected.
Since miRNAs occur in blood in low abundance, these networks
would allow for amplification without using polymerase chain re-
action. In this study, we report initial progress in the development
of a DNA-based cross-catalytic network engineered to amplify spe-
cific cancer-related miRNAs. Subcomponents of the DNA network
were tested individually, and their operation in serum, as well as
a mixture of serum with sodium dodecyl sulfate, is demonstrated.
Preliminary simulations of the full cross-catalytic network indicate
successful operation.
Index Terms—Cancer, catalytic, chemical cascade, chemical net-
work, detection, diagnosis, deoxyribonucleic acid (DNA), entropy
driven, microribonucleic acid (miRNA), strand invasion.
I. INTRODUCTION
WORLDWIDE, there are approximately 1.3 million lungcancer deaths per year [1]. The lives of many individuals
could be improved and/or saved by earlier detection and acces-
sibility to simple detection methods, particularly in remote lo-
cations. Early detection of cancer and decreased mortality rates
Manuscript received December 8, 2009; revised May 25, 2010; accepted June
7, 2010. Date of publication June 21, 2010; date of current version September
9, 2010. This work was supported by the National Institutes of Health under
Grant P20 RR016454 and by the National Science Foundation under Computing
and Communication Foundations Grant 0855212. The review of this paper was
arranged by Associate Editor J. Li.
E. Graugnard, A. Cox, and W. L. Hughes are with the Department of Ma-
terials Science and Engineering, Boise State University, Boise, ID 83725 USA
(e-mail: willhughes@boisestate.edu).
J. Lee is with the Department of Chemistry and Biochemistry, Boise State
University, Boise, ID 83725 USA.
C. Jorcyk is with the Department of Biological Sciences, Boise State Univer-
sity, Boise, ID 83725 USA.
B. Yurke is with the Departments of Materials Science and Engineering and
Electrical and Computer Engineering, Boise State University, Boise, ID 83725
USA.
Color versions of one or more of the figures in this paper are available online
at http://ieeexplore.ieee.org.
Digital Object Identifier 10.1109/TNANO.2010.2053380
are improved by screening technologies [2]. Lung cancer re-
search seeks a noninvasive screening test capable of improving
survival outcomes via early stage detection.
Microribonucleic acids (miRNAs) are small, single-stranded,
noncoding RNAs that are 21–23 nucleotides in length. As gene
regulators, they either suppress the translation or accelerate the
degradation of target messenger RNAs (mRNAs) by binding to
the 3′ untranslated regions [3], [4]. It is estimated that some
miRNAs control hundreds of gene targets, and miRNAs are
involved in the regulation of∼30% of all genes and nearly every
genetic pathway [5]. Evidence also suggests that miRNAs can
function as oncogenes or tumor suppressors [6]–[8]. Besides
their roles in tumor initiation, miRNAs have been found to
play critical roles in several aspects of tumor progression and
metastasis. Furthermore, several miRNAs and the components
of miRNA pathways are amplified in some cancers [9]. Hence,
miRNAs and the components of the miRNA pathway can serve
as targets for early cancer detection, as well as for the discovery
of anticancer agents.
Recently, it has been shown that miRNAs can be detected in
human blood serum [10]. miRNA expression profiling reveals
that miRNA signatures can be used for cancer classification and
prognosis [11]–[13]. For example, miR-25 and miR-223 are
highly expressed in the serum of lung cancer patients [10]. Cur-
rent diagnosis technology requires the isolation of total RNA,
production of complementary deoxyribonucleic acid (cDNA),
and quantitative polymerase chain reaction (PCR) to detect these
miRNAs in serum. However, recent studies have shown that
metastable DNA systems exhibiting catalytic behavior, either
autocatalytic or cross catalytic, can be constructed, thus giv-
ing rise to exponential amplification with large demonstrated
amplification [14], [15]. Since miRNAs occur in serum in low
abundance, these systems would allow for amplification without
using PCR. Here, we present the initial design of a metastable
cross-catalytic DNA system that rearranges to a stable config-
uration upon the input of a specific catalyst miRNA and pro-
duces, as an output signal, strands that generate easily detectable
fluorescence.
By adopting the methodology and labeling convention cre-
ated by Zhang et al. [15], the cross-catalytic DNA system shown
in Fig. 1 was designed to detect and amplify a specific miRNA.
The cross-catalytic system is composed of four distinct com-
ponents: the “translator” [see Fig. 1(a)], the “cross-catalytic
network” [see Fig. 1(b)] and two “reporter” complexes [see
Fig. 1(c) and (d)], each consisting of various DNA strands with
specific domains. The domains correspond to specific DNA se-
quences and are designated by letters or numbers. Subdomains
are indicated with an appended letter (i.e., domain “9” consists
1536-125X/$26.00 © 2010 IEEE
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Fig. 1. Cross-catalytic DNA system for amplifying a specific miRNA. (a) Translator network is an autocatalytic system, whose output strand increases linearly
with time. (b) Output of the translator network serves as one of the two catalysts in the cross-catalytic network, which releases signal strands whose concentration
increases exponentially with time. (c) and (d) Signal strands invade dye-quencher reporter complexes to yield a rapid, easily detectable fluorescent signal. The
yellow circle represents a dye molecule, the circle with a bar represents a quencher molecule, and the black circle represents a quenched dye.
of “9a” and “9b”). Complementary domains are shown with a
bar over the domain name (i.e., domain “9” is the complement
to “9”). The strands have also been color coded according to
their function: catalytic input (black), catalytic output (green),
substrate (pink), fuel (blue), and signal (red).
The translator network [see Fig. 1(a)] consists of several DNA
complexes that include: 1) a “miRNA” catalyst strand; 2) a
“substrate” complex of three strands; 3) a “fuel” strand; and 4)
a “waste” complex. The miRNA catalyst is divided into two
domains m1 and m2 and triggers a chemical cascade, via strand
invasion, without being consumed or altered by the substrate
complex [15]. During chemical amplification, the substrate com-
plex is converted into a waste product through interaction with
a DNA fuel strand. In the absence of a catalyst, this interaction
is inhibited because the complement of the fuel is protected by
the 9 x y 2c strand and a portion of the v m1 h k strand. By
interacting with an internal “toehold,” the catalyst is able to ex-
pose a domain with which the “v” domain of the fuel strand can
hybridize to its complement in an intermediate configuration.
Strand displacement by the fuel then produces a waste product
and releases the 9 x y 2c output strand and the original miRNA
catalyst.
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The 9 x y 2c strand from the translator acts as a catalyst in
the cross-catalytic network [see Fig. 1(b)]. Operation of the two
catalytic loops of the cross-catalytic network is equivalent, so
it suffices to describe the function of one in detail. Consider
the left-hand catalytic loop of the network. The DNA strand
9 x y 2c functions as a catalyst that in the presence of a fuel
strand w z 7 8 9 x operates on the substrate complex consisting of
the strands 4 w z 7 and 6 8 9 x hybridized to strand w z 7 8 9 x y,
given in this case from the 3′ to 5′ direction. The overall reaction
results in the release of the signal strand 6 8 9 x and the strand
4 w z 7, which functions as the catalyst for the right-hand cat-
alytic loop of the network. Four intermediates of the left-hand
loop are displayed in Fig. 1(b). Following the sequence of reac-
tions from top to bottom in Fig. 1, the first intermediate is formed
when the catalyst strand 9 x y 2c attaches itself, via the “y” do-
main, to the complementary overhang on the substrate. The
second intermediate results when the attached catalyst strand
competes with the signal strand 6 8 9 x for binding with the
pink strand of the substrate complex. This process involves re-
versibly passing through a number of transitions via three-way
branch migration. During branch migration, domains 9 x y of the
catalyst strand hybridize with the pink substrate and the signal
strand is attached to the substrate complex only via domain “8,”
which is short, consisting of only four nucleotides. With high
probability this substrate complex dissociates, releasing the sig-
nal strand 6 8 9 x and forming the third intermediate, containing
an exposed “8” domain. The exposed domain provides an attach-
ment site onto which the fuel strand w z 7 8 9 x hybridizes via
the “8” domain, shown as the fourth intermediate in Fig. 1(b).
As a consequence of three-way branch migration, the fuel strand
displaces the catalyst and the output strands. Once displaced, the
output strand functions as a catalyst for the right-hand catalytic
loop. During each half-cycle of the cross-catalytic network, a
fuel strand is consumed, a waste complex is created, and three
strands are released: the original half-cycle catalyst strand, an
output strand that catalyzes the next half-cycle, and a signal
strand. By proper design of the strand domains, the uncatalyzed
system will remain indefinitely in the metastable state.
Note that the catalyst strand is not consumed in the overall
reaction, i.e., it functions as its name implies. The catalyst serves
to initiate the overall reaction, whereby the substrate complex
and the fuel strand are converted into a signal strand, an output
strand, and a waste product. All the intermediate reactions in-
volved in this transformation are reversible. The net change in
the number of base pairs in the overall reaction is zero. Thus,
the reaction is not driven forward enthalpically, but rather by a
net gain in entropy, as the system goes from two components
(the fuel strand and the substrate complex) to three components
(the signal strand, the output strand, and the waste product).
This entropic gain has been shown to be sufficient to drive the
system forward against a decrease of eight base pairs [15].
Since the output strand of each catalytic half-cycle of Fig. 1(b)
serves as a catalyst strand for the other half-cycle, the production
of new catalyst is proportional to the catalyst concentration. This
process gives rise to exponential growth of the catalyst concen-
tration, until depletion of the fuel or substrate strands becomes
significant. Since the number of signal strands produced is pro-
portional to the substrates consumed, they also exhibit expo-
nential growth. Fig. 1(c) and (d) shows the reporter complexes,
which release dye-labeled DNA strands upon strand invasion of
the dye-quencher pairs by signal strands 6 8 9 x and 6 3 4 w.
Thus, the exponential increase in signal strands will result in a
rapid, easily detectable fluorescent signal.
II. EXPERIMENTAL METHODS
Considerable literature exists on the degradation of nucleic
acids by nucleases in body fluids and on methods by which nu-
cleic acids can be made resistant to nuclease activity, especially
for blood [16]–[25]. However, additional studies are required to
address stability and rate issues relevant to the design of cat-
alytic DNA networks for operation in serum or other body flu-
ids. Rate constants for hybridization reactions are of particular
interest, as are rates of degradation of nucleic acids due to nu-
clease activity. Initial experiments were performed to compare
hybridization rates of nucleic acids in phosphate-buffered saline
(PBS) solution and human blood serum. The use of sodium do-
decyl sulfate (SDS) added to serum was explored as a means to
suppress nuclease activity without disrupting DNA hybridiza-
tion. Additionally, operation of the cross-catalytic network has
been confirmed through simulation.
Initial experiments were performed to determine hybridiza-









Each custom strand was purchased and purified from Inte-
grated DNA Technologies, Inc. Stock solutions were prepared
by resuspending the strands in pure water at a nominal con-
centration of 100 µM. The fluorescent strand F, shown red in
Fig. 2, consisted of a 22-nucleotide-long sequence labeled with
tetrachlorofluorescein (TET) dye at the 5′ end (yellow circle).
The emission maximum of the TET dye occurs near 538 nm.
The quencher strand Q, shown blue in Fig. 2, consisted of a
32-nucleotide-long sequence labeled with Iowa Black fluores-
cence quencher at the 3′ end (circle with bar). The absorption
maximum of the quencher occurs near 531 nm. The invader
strand I was an unlabeled 32-nucleotide sequence and was fully
complementary to the quencher strand Q.
All experiments were performed at 20 ◦C with DNA con-
centrations ranging from 2.5 to 50 nM, as determined by ab-
sorption measurements. Control experiments were performed
in 1× PBS, consisting of 0.01 M phosphate buffer and 0.154 M
sodium chloride with a pH of 7.4, purchased from Sigma-
Aldrich, Inc. Experiments testing hybridization in serum were
performed in three separate solutions: 1) 50% serum, consist-
ing of 1× PBS and human serum mixed in equal volumes;
2) 10% SDS, consisting of 1× PBS mixed with 10 wt% SDS;
and 3) 50% serum/10% SDS, consisting of a solution of 1× PBS
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Fig. 2. Hybridization and strand displacement kinetics using FRET. The data
are for the fluorescent (F), quencher (Q), and invader (I) strands at 20 ◦C in
1× PBS buffer. The base sequences for the strands are given in the text. The
initial sample contained strand F. Strand Q was added to the solution at ∼7
min and hybridized with F, as indicated by the decrease in fluorescent intensity
resulting from FRET. At ∼29 min, strand I was added to the solution. The
presence of an available toehold on strand Q allowed the longer I strand to
invade the hybridized dye-quencher pair FQ, robbing the quencher from the dye
and allowing the fluorescence intensity to increase. Strand concentrations were
nominally 50 nM.
with 20 wt% SDS mixed with an equal volume of human serum.
Fluorescence intensity versus time was measured using a Varian
Cary Eclipse spectrofluorometer with standard, plastic 10-mm
cuvettes.
To prepare human serum, whole blood was collected in glass
vacutainer tubes. The blood was allowed to clot in the collection
tubes at room temperature for 30 to 60 min. The tubes were cen-
trifuged at 1100–3000 rev/min for 10 min at room temperature.
One milliliter aliquots of clear serum were transferred to sepa-
rate tubes and stored at −80 ◦C. Serum tubes were allowed to
warm to room temperature prior to hybridization experiments.
Qualitative simulations of the cross-catalytic system were
performed using a DNA-strand-displacement simulator de-
signed for DNA computation [26]. The simulator utilizes a pro-
gramming language centered on strand-displacement reactions
using toeholds and branch migration of DNA structures. The
simulator operates with sequence domains, not at the sequence
level, and thus does not account for secondary structure within
single-stranded DNA segments.
III. RESULTS AND DISCUSSION
A. Measurement of DNA Hybridization Kinetics
Hybridization and strand-displacement kinetics using fluo-
rescence resonant energy transfer (FRET) are shown in Fig. 2.
For initial tests, the strand F in Fig. 2 is a dye-modified DNA
analogue of the miR-451 base sequence that was chosen as it
is found at high abundance in normal blood and is nonspecific
to cancer [10]. Fig. 2(left) shows the normalized fluorescence
intensity of strand F in 1× PBS. Strand Q has a base sequence
that is fully complementary to F and in addition has the ten
extra base sequence GTAGTGTGGG at the 5′ end that forms
an unhybridized toehold when F and Q hybridize to form the
complex FQ. As a result, when F and Q hybridize, the 538-nm
TET fluorescence emission is quenched by the 531-nm Iowa
Black quencher absorption via FRET [27]. This process allows
the kinetics of hybridization of F with Q to be followed by mon-
itoring the TET fluorescence intensity, as shown in Fig. 2(mid-
TABLE I
HYBRIDIZATION AND STRAND-INVASION RATES FOR THE F, Q, AND I DNA
STRANDS IN VARIOUS SOLUTIONS
dle), where strand Q was added to the solution at ∼7 min.
Strand I is fully complementary to Q and, via competitive bind-
ing mediated by the toehold, is able to displace F from the
FQ complex by a strand-invasion process. The kinetics of this
strand-displacement process can be monitored by observing the
recovery of fluorescence intensity as the F strands are released
from the FQ complex, as shown in Fig. 2(right), where strand I
was added at ∼29 min.
The rates of hybridization of F with Q and the rates of strand
invasion of I into the complex FQ were determined by fitting
the data with the appropriate rate equation and are listed in
Table I [27]. The hybridization data indicate that hybridization
occurs at comparable rates for each of the three cases. The
strand-invasion rate constants are within an order of magnitude
of each other. In these experiments, each strand was present
at 50 nM concentration, except for the case of strand invasion
in 10% SDS for which each strand was present at a 10-nM
concentration.
It is noted that strand I decays at a rate of 0.024 s−1 in pure
serum, and it was necessary to take this into account in ob-
taining the rate constant for strand invasion in the pure serum
case. Degradation of the F and Q strands and the FQ complex
in serum was considerably slower due to protection provided
by the end modifications of these strands and due to the fact
that duplex DNA degrades less rapidly in serum than unmod-
ified single-stranded DNA [22]. The entropy-driven catalytic
network is based on strand-displacement reactions. These pre-
liminary experiments show that such reactions occur in serum
and serum-SDS at rates comparable to those in PBS. These re-
sults indicate that catalytic networks tested in PBS buffer should
operate successfully in serum-SDS.
B. RNA Hybridization with DNA
An experiment was performed to assess the hybridization of
RNA with DNA. Synthetically produced miR-451, RNA hav-
ing sequence 5′-AAACCGUUACCAUUACUGAGUU-3′, was
hybridized with a probe DNA consisting of the complemen-
tary sequence with Cy5 dye at the 5′ end and Iowa Black
RQ quencher at the 3′ end. This experiment was performed
in 1× PBS with the DNA strand at a concentration of 25 nM
and the RNA strand at 10 nM. The rate constant, determined by
fitting fluorescence intensity versus time curves, was measured
to be 3.2 × 105 M−1s−1 (data not shown). This rate is compara-
ble to the DNA–DNA hybridization rate between cDNA strands
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of length similar to that of the miRNA. Thus, hybridization
experiments using the DNA analogs of miRNAs should provide
accurate tests of the cross-catalytic system.
C. Toehold-Mediated Strand Invasion by RNA
An experiment was performed to assess the effectiveness
of toehold-mediated strand displacement by RNA. In this ex-
periment, the DNA strands 5′-(TET)-AAACCGTTACCATT
ACT-3′ (shortened version of F) and 5′-AACTCAGTAATGG
TAACGGTTT-(Iowa Black FQ)-3′ (shortened version of Q)
were first hybridized together to form a duplex in which the
fluorescent dye and the quencher are next to each other at one
end of the duplex, and for which, an overhang consisting of
the sequence AACTC occurs at the other end. This overhang
functions as a toehold to which the synthetically produced miR-
451 can attach to initiate strand invasion. The experiment was
performed in 1× PBS buffer with the strands at a concentra-
tion of 25 nM. From fluorescence intensity versus time data,
the rate with which the TET-labeled strand was displaced from
the complex was measured to be 7.5 × 103 M−1s−1 (data not
shown). This rate is roughly one order of magnitude lower than
an all DNA-based system having an overhang of five bases [28].
This experiment indicates that DNA hybridization experiments
serve as a useful guide for the performance of nucleic-acid-
hybridization networks in which some of the strands consist of
RNA.
D. DNA and RNA Degradation in Serum and Serum/SDS
As mentioned in Section III-A, unprotected DNA strands are
rapidly degraded in serum due to nuclease activity. To assess
the effectiveness of SDS in suppressing nuclease activity, an
experiment was performed in which the fluorescence intensity
of the FQ complex was monitored as a function of time. Should
the FQ complex be degraded by nuclease activity, the TET dye
or Iowa Black quencher would be released. Hence, monitoring
the fluorescence-intensity increase as a function of time provides
an indication of the stability of the FQ complex. An experiment
was performed in which FQ was added to 1× PBS, 50% serum,
10% SDS, and 50% serum/10% SDS. The fluorescence intensity
versus time plots are shown in Fig. 3. Only the 50% serum
sample (serum mixed with an equal volume of 1× PBS) showed
appreciable fluorescence increase. The fluorescence intensity
of the remaining samples was relatively stable with variations
attributable to instrument instability. The experiments indicate
that SDS is effective in suppressing nuclease activity.
E. Simulation of the Catalytic Network
Prior to experimental testing, operation of the cross-catalytic
network was simulated to verify proper design of the DNA
strand domains. Simulations were performed using a domain-
level strand-displacement computational system designed for
DNA [26]. The simulator input file lists the concentration (in
arbitrary units) and domain structure of all single-stranded and
double-stranded complexes that would be present in solution.
Using toehold-mediated strand invasion and branch migration,
Fig. 3. DNA and RNA degradation in serum and serum-SDS. Degradation of
hybridized DNA strands (FQ) was assessed by fluorescence intensity increases
as dye-quencher pairs were separated via nuclease activity. Experiments were
performed in which FQ was added to 1× PBS, 50% serum, 10% SDS, and 50%
serum/10% SDS. The stability of double-stranded DNA was greatly increased
in the 50% serum/10% SDS solution.
Fig. 4. Simulations of the cross-catalytic network shown in Fig. 1(b)–(d)
where “1” refers to components of the left-hand loop and “2” refers to those from
the right-hand loop. (a) With no added catalyst (9 x y 2c), the DNA complexes
are stable in time, forming only complexes that do not release Signal strands.
(b) Once the catalyst for substrate 1 is added, the cross-catalytic reactions
proceed, rapidly producing large amounts of the dye-labeled strands, along with
various other double-stranded complexes.
the simulator then solves for all possible hybridization and in-
vasion reactions. Strand interactions then proceed through the
possible reactions for a fixed number of time steps with the re-
sulting concentrations of each single- and double-stranded com-
plex determined by the simulator. Fig. 4(a) shows the simulated
cross-catalytic network (with all initial components shown in
Fig. 1(b)–(d), i.e., substrates, fuels, and reporters) with no cata-
lyst (9 x y 2c) added to the system. In Fig. 4, components labeled
with a “1” refer to the left-hand loop of Fig. 1(b) and the re-
porter of Fig. 1(c), whereas components labeled with a “2” refer
to the right-hand loop of Fig. 1(b) and the reporter of Fig. 1(d).
Double-stranded substrate/fuel and reporter/fuel complexes are
formed; however, no signal strands, and thus, no dye-labeled
strands are released, thus indicating that the cross-catalytic net-
work is stable in time.
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As seen in Fig. 4(b), once strand 9 x y 2c, the catalyst for the
left-hand half-cycle, is added to the system, the cross-catalytic
reactions proceed rapidly, as predicted. Several intermediates
and double-stranded complexes are formed; however, the pri-
mary result is the rapid release of large amounts of dye-labeled
strands from the reporter complexes. The rates and quantities of
the released dye-labeled strands are equal to the rates and quanti-
ties of signal strands that react with the reporter complexes. The
amount of released signal strand is controlled by the quantities
of available fuel strands and substrate complexes. Thus, the rate
of dye release slows significantly as the fuel and substrates be-
come depleted. Although secondary structure and interference
between domains must be accounted for independently from the
simulator, these simulation results indicate proper operation of
the cross-catalytic system at the domain level.
IV. CONCLUSION
Levels of specific miRNA in human blood can be used for
cancer diagnosis. A cross-catalytic DNA-based chemical am-
plifier has been designed to amplify specific miRNA in serum.
The modular construction of the cross-catalytic system should
facilitate design optimization and troubleshooting. Each cat-
alytic loop can be independently operated and tested from the
others. All strands not containing the domains m1 or m2 can be
chosen to have base sequences unrelated to miRNA sequences.
As a result, most of the system can be designed and optimized
such that only the m1 and m2 domains and their complements
need to be changed, in order to use the system for the detection
of a different miRNA. The modular design will also allow the
system to be operated in a variety of modes by leaving out indi-
vidual components. This cross-catalytic system is attractive for
use as a miRNA detector in serum, since the separate system
components have long-term stability and cross-catalytic systems
exhibiting exponential growth of the catalyst concentration will
be driven to completion more rapidly than systems that rely on
the turnover of a single catalyst.
In addition to catalytic systems, DNA-based chemical net-
works that can perform Boolean logic functions have been
devised [14], which allow the possibility of building DNA-
based miRNA detectors that detect relative concentrations of
a particular set of miRNAs. As the presence of specific cancers
may be related to relative increased levels of several miRNA,
concentration-dependent detection may result in greater selec-
tivity in medical diagnosis through miRNA expression profiling.
DNA kinetics studies were performed in human blood serum
with and without SDS. Hybridization rates in all solutions were
within one order of magnitude of each other for both DNA and
RNA. With 10% SDS, DNA lifetime in serum is increased. Ad-
dition of SDS to serum should allow the cross-catalytic system
to amplify cancer specific miRNA.
Simulations of the cross-catalytic system indicate that the sys-
tem remains in a metastable state, until a catalyst DNA strand
is added to the system. Once the catalyst strand is added, dye-
labeled DNA strands are rapidly released into the solution, pro-
viding a large, easily detectable fluorescence signal.
ACKNOWLEDGMENT
The authors would like to thank W. B. Knowlton, E. Winfree,
and L. Qian for support and insightful discussions of this paper.
REFERENCES
[1] World Health Organization. (2009, Feb.). Cancer. [Online]. Available:
http://www.who.int/mediacentre/factsheets/fs297/en/print.html
[2] American Cancer Society. (2009). Cancer Facts and Figures 2009. [On-
line]. Available: http://www.cancer.org/docroot/STT/STT_0.asp
[3] L. He and G. J. Hannon, “MicroRNAs: Small RNAs with a big role in
gene regulation,” Nat. Rev. Genet., vol. 5, pp. 522–531, Jul. 2004.
[4] R. W. Carthew, “Gene regulation by microRNAs,” Curr. Opin. Genet.
Dev., vol. 16, pp. 203–208, Apr. 2006.
[5] H.-W. Hwang and J. T. Mendel, “MicroRNAs in cell proliferation, cell
death, and tumorigenesis,” Br. J. Cancer, vol. 94, pp. 776–780, Jun.
2006.
[6] A. Cimmino, G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin, M. Shimizu,
S. E. Wojcik, R. I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder,
S. Volinia, C.-g. Liu, T. J. Kipps, M. Negrini, and C. M. Croce, “miR-15
and miR-16 induce apoptosis by targeting BCL2,” Proc. Nat. Acad. Sci.
USA, vol. 102, pp. 13944–13949, Sep. 2005.
[7] L. He, J. M. Thomson, M. T. Hemann, E. Hernando-Monge, D. Mu,
S. Goodson, S. Powers, C. Cordon-Cardo, S. W. Lowe, G. J. Hannon,
and S. M. Hammond, “A microRNA polycistron as a potential human
oncogenes,” Nature, vol. 435, pp. 828–833, Jun. 2005.
[8] J. A. Chan, A. M. Krichevsky, and K. S. Kosik, “MicroRNA-21 is an
antiapoptotic factor in human glioblastoma cells,” Cancer Res., vol. 65,
pp. 6029–6033, Jul. 2005.
[9] L. Zhang, S. Volinia, T. Bonome, G. A. Calin, J. Greshock, N. Yang,
C.-G. Liu, A. Giannakakis, P. Alexiou, K. Hasegawa, C. N. Johnstone,
M. S. Megraw, S. Adams, H. Lassus, J. Huang, S. Kaur, S. Liang, P.
Sethupathy, A. Leminen, V. A. Simossis, R. Sandaltzopoulos, Y. Naomoto,
D. Katsaros, P. A. Gimotty, A. DeMichele, Q. Huang, R. Bu¨tzow, A. K.
Rustgi, B. L. Weber, M. J. Birrer, A. G. Hatzigeorgiou, C. M. Croce, and
G. Coukos, “Genomic and epigenetic alterations deregulate microRNA
expression in human epithelial ovarian cancer,” Proc. Nat. Acad. Sci.
USA, vol. 105, pp. 7004–7009, May 2008.
[10] X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang,
J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang,
Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong,
G. Ning, J. Wang, K. Zen, J. Zhang, and C.-Y. Zhang, “Characteriza-
tion of microRNAs in serum: A novel class of biomarkers for diagnosis
of cancer and other diseases,” Cell Res., vol. 18, pp. 997–1006, Oct.
2008.
[11] G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,”
Nat. Rev. Cancer, vol. 6, pp. 857–866, Nov. 2006.
[12] J. Lu, G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck,
A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing,
T. Jacks, H. R. Horvitz, and T. R. Golub, “MicroRNA expression profiles
classify human cancers,” Nature, vol. 435, pp. 834–838, Jun. 2005.
[13] S. Volinia, G. A. Calin, C.-G. Liu, S. Ambs, A. Cimmino,
F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt,
N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Har-
ris, and C. M. Croce, “A microRNA expression signature of human solid
tumors defines cancer gene targets,” Proc. Nat. Acad. Sci. USA, vol. 103,
pp. 2257–2261, Feb. 2005.
[14] G. Seelig, B. Yurke, and E. Winfree, “Catalyzed relaxation of a metastable
DNA fuel,” J. Amer. Chem. Soc., vol. 128, pp. 12211–12220, 2006.
[15] D. Y. Zhang, A. J. Turberfield, B. Yurke, and E. Winfree, “Engineer-
ing entropy-driven reactions and networks catalyzed by DNA,” Science,
vol. 318, pp. 1121–1125, Nov. 2007.
[16] R. S. Geary, “Antisense oligoncleotide pharmacokinetics and
metabolism,” Expert Opin. Drug Metab Toxicol., vol. 5, pp. 381–391,
Apr. 2009.
[17] M. K. Osako, N. Tomita, H. Nakagami, Y. Kunugiza, M. Yoshino,
K. Yuyama, T. Tomita, H. Yoshikawa, T. Ogihara, and R.
Morishita, “Increase in nuclease resistance and incorporation of
NF-κB decoy oligodeoxynucleotides by modification of the 3′-terminus,”
J. Gene Med., vol. 9, pp. 812–819, Jul. 2007.
[18] D. A. Di Giusto and G. C. King, “Construction, stability, and activity of
multivalent circular anticoagulant aptamers,” J. Biol. Chem., vol. 279,
pp. 46483–46489, Aug. 2004.
GRAUGNARD et al.: KINETICS OF DNA AND RNA HYBRIDIZATION IN SERUM AND SERUM-SDS 609
[19] G. Re¸bowski, M. Wo´jcik, M. Boczkowska, E. Gendaszewska,
M. Soszyoski, G. Bartosz, and W. Niewiarowski, “Antisense hairpin
loop oligonucleotides as inhibitors of expression of multidrug resistance-
associated protein 1: Their stability in fetal calf serum and human plasma,”
Acta Biochim. Polon., vol. 48, pp. 1061–1076, 2001.
[20] T. D. Samani, B. Jolles, and A. Laigle, “Best minimally modified antisense
oligonucleotides according to cell nuclease activity,” Antisense Nucleic
Acid Drug Dev., vol. 11, pp. 129–136, Jun. 2001.
[21] R. Piva, E. Lambertini, L. Penolazzi, M. C. Facciolo, A. Lodi, G. Aguiari,
C. Nastruzzi, and L. del Senno, “In vitro stability of polymerase chain
reaction-generated DNA fragments in serum and cell extracts,” Biochem.
Pharmacol., vol. 56, pp. 703–708, Sep. 1998.
[22] B. C. F. Chu and E. Orgel, “The stability of different forms of double-
stranded decoy DNA in serum and nuclear extracts,” Nucleic Acids Res.,
vol. 20, pp. 5857–5959, Nov. 1992.
[23] R. J. Boado and W. M. Pardridge, “Complete protection of antisense
oligonucleotides against serum nuclease degradation by an avidin-biotin
system,” Bioconjugate Chem., vol. 3, pp. 519–523, Nov. 1992.
[24] J.-P. Shaw, K. Kent, J. Bird, J. Fishback, and B. Froehler, “Modified de-
oxyoligonucleotides stable to exonuclease degradation in serum,” Nucleic
Acids Res., vol. 19, pp. 747–750, Feb. 1991.
[25] G. D. Hoke, K. Draper, S. M. Freier, C. Gonzalez, V. B. Driver, M. C.
Zounes, and D. J. Ecker, “Effects of phosphorothioate capping on antisense
oligonucleotide stability, hybridization and antiviral efficacy versus herpes
simplex virus infection,” Nucleic Acids Res., vol. 19, pp. 5743–5748, Oct.
1991.
[26] A. Phillips and L. Cardelli, “A programming language for composable
DNA circuits,” J. R. Soc. Interface, vol. 6, pp. S419–S436, Jun. 2009.
[27] L. E. Morrison and L. M. Stols, “Sensitive fluorescence-based thermo-
dynamic and kinetic measurements of DNA hybridization in solution,”
Biochemistry, vol. 32, pp. 3095–3104, Mar. 1993.
[28] B. Yurke and A. P. Mills, Jr., “Using DNA to power nanostructures,”
Genet. Program. Evolvable Mach., vol. 4, pp. 111–122, Jun. 2003.
Author’s photographs and biographies not available at the time of publication.
